Reading and Writing in Russian: The Neglected Skills?KIRKWOOD J. M.Journal of Russian Studies. 1976, Num 32, pp 13-23Article

Reading and writing in Russian: The Neglected Skills?KIRKWOOD J. M.Journal of Russian Studies. 1976, Num 32, pp 13-23Article

Osnovy Zinov'evizmaKIRKWOOD, J. M.Journal of Russian Studies Nottingham. 1983, Num 46, pp 39-48Article

The developmental rate of Euphausia crystallorophias larvae in Ellis Fjord, Vestfold Hills, AntarcticaKIRKWOOD, J. M.Polar biology (Print). 1996, Vol 16, Num 7, pp 527-530, issn 0722-4060Article

Studies of interferons in the therapy of melanomaKIRKWOOD, J. M.Seminars in oncology. 1991, Vol 18, Num 5, pp 83-90, issn 0093-7754, SUP7Article

Systemic adjuvant treatment of high-risk melanoma : The role of interferon alfa-2b and other immunotherapiesKIRKWOOD, J. M.European journal of cancer. Supplement (1990). 1998, Vol 34, Num 3, pp S12-S17, issn 1359-6349Conference Paper

New clinical trials with interleukin-2: rationale for regional administrationROTH, A. D; KIRKWOOD, J. M.Natural immunity and cell growth regulation. 1989, Vol 8, Num 3, pp 153-164, issn 0254-7600, 12 p.Article

Analysis of granulocyte-macrophage progenitor cells in patients treated with recombinant interferon alpha-2ERNSTOFF, M. S; GALLICCHIO, V; KIRKWOOD, J. M et al.The American journal of medicine. 1985, Vol 79, Num 2, pp 167-170, issn 0002-9343Article

Serial studies of autologous antibody reactivity to melanoma: relationship to clinical course and circulating immune complexesVLOCK, D. R; KIRKWOOD, J. M.The Journal of clinical investigation. 1985, Vol 76, Num 2, pp 849-854, issn 0021-9738Article

Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapyLOGAN, T. F; BANNER, B; RAO, U et al.Clinical and experimental immunology (Print). 1998, Vol 114, Num 3, pp 347-354, issn 0009-9104Article

Future perspectives in specific immunotherapy of melanomaPARMIANI, G.European journal of cancer. Supplement (1990). 1998, Vol 34, Num 3, pp S42-S47, issn 1359-6349Conference Paper

Incidence, risk factors and prevention of melanomaMACKIE, R. M.European journal of cancer. Supplement (1990). 1998, Vol 34, Num 3, pp S3-S6, issn 1359-6349Conference Paper

Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastasesROSS, M. I; REINTGEN, D. S.European journal of cancer. Supplement (1990). 1998, Vol 34, Num 3, pp S7-S11, issn 1359-6349Conference Paper

Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanomaKIRKWOOD, J. M; WILSON, J; WHITESIDE, T. L et al.Cancer immunology and immunotherapy. 1997, Vol 44, Num 3, pp 137-149, issn 0340-7004Article

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma : the Eastern Cooperative Oncology Group trial EST 1684KIRKWOOD, J. M; STRAWDERMAN, M. H; ERNSTOFF, M. S et al.Journal of clinical oncology. 1996, Vol 14, Num 1, pp 7-17, issn 0732-183XArticle

Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck : an eastern cooperative oncology group trialVLOCK, D. R; SNYDERMAN, C. H; JOHNSON, J. T et al.Journal of immunotherapy. 1994, Vol 15, Num 2, pp 134-139, issn 1053-8550Article

Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanomaSELVAGGI, K; SARIA, E. A; SCHWARTZ, R et al.Journal of immunotherapy. 1993, Vol 13, Num 3, pp 201-207, issn 1053-8550Article

Depressed ability of patients with melanoma or renal cell carninoma to generate adherent lymphokine-activated killer cellsSEDLMAYR, P; RABINOWICH, H; ELDER, E. M et al.Journal of immunotherapy. 1991, Vol 10, Num 5, pp 336-346, issn 1053-8550Article

Dysplastic nevi in association with multiple primary melanomaTITUS-ERNSTOFF, L; DURAY, P. H; ERNSTOFF, M. S et al.Cancer research (Baltimore). 1988, Vol 48, Num 4, pp 1016-1018, issn 0008-5472Article

Immune response to autologous human melanoma: implication of class I and II MHC productsFOSSATI, G; ANICHINI, A; TARAMELLI, D et al.Biochimica et biophysica acta. 1986, Vol 865, Num 3, pp 235-251, issn 0006-3002Article

Analysis of two human monoclonal antibodies against melanomaYEILDING, N. M; GERSTNER, C; KIRKWOOD, J. M et al.International journal of cancer. 1992, Vol 52, Num 6, pp 967-973, issn 0020-7136Article

Human IgG and IgM monoclonal antibodies against autologous melanoma produced by epstein-barr-virus-transformed B lymphocytesKIRKWOOD, J. M; ROBINSON, J. E.Cancer immunology and immunotherapy. 1990, Vol 32, Num 4, pp 228-234, issn 0340-7004Article

Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serumKIRKWOOD, J. M; VLOCK, D. R.Cancer research (Baltimore). 1984, Vol 44, Num 9, pp 4177-4182, issn 0008-5472Article

Malignant melanoma: Current controversies, future perspectives. SymposiumEGGERMONT, A. M. M; KIRKWOOD, J. M.European journal of cancer. Supplement (1990). 1998, Vol 34, Num 3, issn 1359-6349, 49 p.Conference Proceedings

Macrobenthic species assemblages in Ellis Fjord, Vestfold Hills, AntarcticaKIRKWOOD, J. M; BURTON, H. R.Marine biology (Berlin). 1988, Vol 97, Num 3, pp 445-457, issn 0025-3162Article